CardioTech gets FDA OK for wound dressing:
This article was originally published in Clinica
The US FDA has given CardioTech International the green light to sell its new line of wound dressings designed to treat exuding and bleeding wounds. Representing an advanced wound dressing, AlgiMed absorbs wound exude almost instantaneously, and helps control minor bleeding, said the Woburn, Massachusetts firm. Made of calcium alginate, the dressing releases calcium - a potent pro-coagulant - on contact with blood, thus stopping bleeding. CardioTech expects to start selling the product in January 2004. It estimated the advanced wound care market at $1.5bn.